Henovcom is invited to participate in the 4th mRNA-Based Therapeutics Summit?in Frankfurt, Germany. The CEO,?Jiancun Larry Zhang, will give a presentation titled?“Novel & Efficient Cap Analogs & Ionizable Lipids for mRNA Based Vaccines & Therapeutics”?and will?participate in a case study poster session.
The 4th mRNA-Based Therapeutics Summit?Europe is?the industry’s premier forum dedicated to showcasing the hottest disease targets, never-before-seen pre-clinical and clinical data, and demonstrating key routes to commercial success for mRNA therapy and vaccine R&D pipelines.
Topic: Novel & Efficient Cap Analogs &?Ionizable Lipids for mRNA Based Vaccines & Therapeutics
Date:?CONFERENCE DAY one, Wednesday 29th January
Time: 11:45?a.m.
Speaker:?Jiancun Larry Zhang
? ? ? Chief Executive Officer
Key points:
??Novel trinucloside AG and AU cap analogs amenable to?synthesizing mRNAs and saRNAs with an enhanced protein?expression profile
??One-pot synthesis of fluorescently labeled mRNA for real-time in?vitro and in vivo tracking, and mRNA delivery system screening
??Efficient and fast degrading ionizable lipid for mRNA LNP?delivery
??Application of LZCaps in mRNA vaccines and protein?replacement therapies
?
Conference Website：https://mrnabased-therapeutics-europe.com/
